Latest Mergers And Acquisitions News

Oracle has completed a sizeable capital raising combining US$10 billion of notes with the issue of 86.2 million common shares. The company has not yet specified how the proceeds will be divided between investment, debt repayment, acquisitions, dividends or buybacks.

STERIS delivered 9% second-quarter revenue growth and lifted its fiscal 2027 adjusted EPS outlook, helped partly by tariff refunds. Life Sciences led the operating gains, while weaker cash flow and a new restructuring plan add important qualifications.

Host Hotels delivered an 8.8% rise in comparable hotel RevPAR and lifted its 2026 growth targets, despite a sharp quarterly fall in GAAP net income. Two acquisitions and a cheaper, longer-dated credit facility add a second layer to the lodging REIT’s expansion story.

Desane Group Holdings (ASX:DGH) is entering FY27 with a $105.9 million asset base, conservative gearing and two developments expected to drive its next phase of earnings. The challenge is converting that balance-sheet strength into recurring income while navigating construction costs, funding risk and a chairman transition.

hipages Group delivered stronger FY26 cash generation and record margins, but now expects FY27 revenue, profitability and free cash flow to land at the lower ends of its existing targets. Management says deteriorating economic conditions have slowed activity in some discretionary home-improvement categories.

Kuniko has intersected mineralisation in all five Phase 2 holes at Silica Hill, extending the interpreted gold-silver-base-metal system beyond the historical resource footprint. The results include a 16.3-metre interval grading 1.56 g/t gold equivalent, while new geophysical targets point to further exploration beyond the drilled area.

Canterbury Resources has opened a non-underwritten share purchase plan targeting approximately A$1 million for drilling at its John Hill copper-molybdenum deposit. The company may accept up to A$2.5 million, while all five directors have indicated they intend to participate.

Edwards Lifesciences delivered stronger-than-expected third-quarter growth and lifted its full-year 2026 outlook, led by a sharp rise in mitral and tricuspid therapies. A US$220.2 million impairment charge remains a notable counterpoint to the upbeat operating performance.

Corazon Mining has intersected gold across roughly 450 metres south of the historical Chalice pit, with mineralisation found in 23 of 29 RC holes reported. The results support the geological model behind a larger conceptual exploration target, while five holes testing up to 800 metres south remain pending.

Right Resources has identified a 3-kilometre interpreted shear zone hosting surface tungsten mineralisation at its Moonlight Prospect in New South Wales. Initial rock-chip assays reached 0.61% WO3, but drilling is still needed to establish continuity, scale and economic significance.

Strategic Elements has secured its first commercial mining contract for Stealth Technologies’ EdgeiQ OnSite platform, worth approximately A$225,000 initially. A separate EdgeiQ Portable pilot has also launched after five underground trials with a Tier 1 mining company, giving the venture two potential routes into mining operations.

SSH Group has reduced hire purchase debt by approximately $7.5 million to $12.8 million while retaining a fleet of more than 250 rental assets. The company has also completed the first phase of its EMS integration, but its proposed Crawford Gold mining contract remains unsigned.